期刊
VIRULENCE
卷 12, 期 1, 页码 989-1002出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21505594.2021.1903691
关键词
Staphylococcus pseudintermedius; nuclease; adenosine synthase A; deoxyadenosine; abscess
资金
- Hannover Biomedical Research School (HBRS)
- Center for Infection Biology (ZIB)
- German Research Foundation [WI4582/2-1, 449712894]
MRSP, an emerging zoonotic pathogen of canine origin, relies on specific enzymes NucB and AdsA for pathogenesis, leading to selective killing of host immune cells through a specific pathway, which may aid in the development of new therapeutic strategies.
Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is an emerging zoonotic pathogen of canine origin that causes an array of fatal diseases, including bacteremia and endocarditis. Despite large-scale genome sequencing projects have gained substantial insights into the genomic landscape of MRSP, current knowledge on virulence determinants that contribute to S. pseudintermedius pathogenesis during human or canine infection is very limited. Using a panel of genetically engineered MRSP variants and a mouse abscess model, we here identified the major secreted nuclease of S. pseudintermedius designated NucB and adenosine synthase A (AdsA) as two synergistically acting enzymes required for MRSP pathogenesis. Similar to Staphylococcus aureus, S. pseudintermedius requires nuclease secretion along with the activity of AdsA to degrade mammalian DNA for subsequent biosynthesis of cytotoxic deoxyadenosine. In this manner, S. pseudintermedius selectively kills macrophages during abscess formation thereby antagonizing crucial host immune cell responses. Ultimately, bioinformatics analyses revealed that NucB and AdsA are widespread in the global S. pseudintermedius population. Together, these data suggest that S. pseudintermedius deploys the canonical Nuc/AdsA pathway to persist during invasive disease and may aid in the development of new therapeutic strategies to combat infections caused by MRSP.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据